JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Venning, J. D.
Right arrow Articles by Jackson, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Venning, J. D.
Right arrow Articles by Jackson, J. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 44, Issue of October 31, 1997 pp. 27535-27538

COMMUNICATION:
Evidence That the Transfer of Hydride Ion Equivalents between Nucleotides by Proton-translocating Transhydrogenase Is Direct*

(Received for publication, July 12, 1997, and in revised form, September 9, 1997)

Jamie D. Venning , Rachel L. Grimley , Tania Bizouarn , Nick P. J. Cotton and J. Baz Jackson Dagger

From the School of Biochemistry, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

The molecular masses of the purified, recombinant nucleotide-binding domains (domains I and III) of transhydrogenase from Rhodospirillum rubrum were determined by electrospray mass spectrometry. The values obtained, 40,273 and 21,469 Da, for domains I and III, respectively, are similar to those estimated from the amino acid sequences of the proteins. Evidently, there are no prosthetic groups or metal centers that can serve as reducible intermediates in hydride transfer between nucleotides bound to these proteins. The transient-state kinetics of hydride transfer catalyzed by mixtures of recombinant domains I and III were studied by stopped-flow spectrophotometry. The data indicate that oxidation of NADPH, bound to domain III, and reduction of acetylpyridine adenine dinucleotide (an NAD+ analogue), bound to domain I, are simultaneous and very fast. The transient-state reaction proceeds as a biphasic burst of hydride transfer before establishment of a steady state, which is limited by slow release of NADP+.

Hydride transfer between the nucleotides is evidently direct. This conclusion indicates that the nicotinamide rings of the nucleotides are in close apposition during the hydride transfer reaction, and it imposes firm constraints on the mechanism by which transhydrogenation is linked to proton translocation.


INTRODUCTION

Transhydrogenase is found in the inner membranes of animal mitochondria and the cytoplasmic membranes of some bacteria. It couples the transfer of hydride ion equivalents between NAD(H) and NADP(H) to the translocation of protons across the membrane. The net reaction is as follows.
<UP>NADH</UP>+<UP>NADP<SUP>+</SUP></UP>+<UP>H</UP><SUP><UP>+</UP></SUP><SUB><UP>out</UP></SUB><UP> ⇔ NAD<SUP>+</SUP></UP>+<UP>NADPH</UP>+<UP>H</UP><SUP><UP>+</UP></SUP><SUB><UP>in</UP></SUB> (Eq. 1)
For many years, the question as to whether hydride transfer between the nucleotides is direct or indirect has been a matter of controversy. It is central to our understanding of the energy-coupling reactions.

Transhydrogenase comprises three domains. Domains I and III protrude from the membrane (on the matrix side in mitochondria and on the cytoplasmic side in bacteria). Domain II spans the membrane. There are separate sites on the enzyme for NAD(H) and for NADP(H); the former is located on domain I, and the latter on domain III (for reviews, see Refs. 1-3).

The results of some early experiments on transhydrogenases from mitochondria and from Rhodospirillum rubrum were interpreted as evidence for the existence of a stable, reduced-enzyme intermediate (4-6). It was implied that a functional group on the enzyme, presumably either an amino acid residue or an unidentified prosthetic group, can serve alternately as a hydride acceptor and hydride donor. For example,
E+<UP>NADH ⇔ </UP>E(<UP>H</UP>)+<UP>NAD<SUP>+</SUP></UP> (Eq. 2)
E(<UP>H</UP>)+<UP>NADP<SUP>+</SUP> ⇔ </UP>E+<UP>NADPH</UP> (Eq. 3)
where E(H) represents the reduced-enzyme intermediate. However, in subsequent work other plausible explanations were found for the earlier data (7, 8). Moreover, the conclusions from steady-state kinetic analysis of transhydrogenase from various sources (7, 9-11) have been interpreted as evidence that the reaction proceeds through the formation of a ternary complex of enzyme and nucleotide substrates. The addition of nucleotides is random, and fast, relative to the rate of a subsequent step in turnover. The reaction does not appear to take place via a substituted enzyme mechanism, and therefore the existence of a reduced enzyme intermediate, which is stable in the absence of nucleotide, is unlikely (viz. reactions exemplified by Equations 2 and 3). However, the steady-state data do not rule out the possible existence of a reduced enzyme intermediate within the ternary complex, that is a reaction of the following type.
E+<UP>NADH</UP>+<UP>NADP<SUP>+</SUP> ⇔ NADH·</UP>E<UP>·NADP<SUP>+</SUP> ⇔ NAD<SUP>+</SUP>·</UP>E(<UP>H</UP>)<UP>·NADP<SUP>+</SUP> ⇔ </UP> (Eq. 4)
<UP>NAD<SUP>+</SUP>·E·NADPH ⇔ </UP>E+<UP>NAD<SUP>+</SUP></UP>+<UP>NADPH</UP>
The possibility that Cys residues in the polypeptide chain might serve as reducible intermediates in hydride transfer (see, for example, Refs. 1 and 12) has been eliminated by amino acid sequence comparisons, there are no conserved Cys residues in transhydrogenases from different species, and by the fact that complete Cys replacement has only a minimal effect on transhydrogenation activity (13). It is unlikely that other amino acid residues have redox potentials in the appropriate range to serve as intermediates in transhydrogenation between NAD(H) and NADP(H). It has sometimes been stated in the literature that transhydrogenase is devoid of prosthetic groups that might be involved in the hydride transfer pathway, although our survey indicates that studies are incomplete. 1) It was established many years ago that there is no detectable flavin fluorescence from purified preparations of the mitochondrial enzyme (14). 2) Analyses of amino acid sequences of transhydrogenases do not reveal the existence of metal-binding motifs. 3) It has been shown that concentrated solutions of the highly purified recombinant domains I and III (which together are catalytically active, see below) do not have any absorbance that might be attributable to chromophoric groups in the proteins (15, 16). However, we are unaware of studies on transhydrogenase which rule out the presence of weakly, or nonabsorbing, prosthetic groups. By analogy with dehydrogenases, a number of possible prosthetic groups or metal ions might be envisaged to have a role as an intermediate in hydride transfer. For example, in view of the strong sequence similarity between transhydrogenase and the soluble enzyme alanine dehydrogenase (17), covalently bound pyruvate might be considered as a potential hydride acceptor.

A mixture of the isolated recombinant forms of domains I and III of R. rubrum transhydrogenase catalyzes the so-called "cyclic reaction" at a rate approaching that observed with the complete, membrane-located enzyme (16, 18). Evidently the complex of domains I and III is capable of rapid rates of hydride transfer, even in the absence of membrane-spanning domain II, and thus the apparatus for hydride transfer is located entirely within the two peripheral domains. We report below on the use of electrospray mass spectrometry to determine accurately the molecular masses of these peripheral domains with a view to establishing whether or not they possess covalently bound groups that might participate in the hydride transfer reaction. We also describe an experiment in which we examine the pre-steady-state kinetics of transhydrogenation catalyzed by a mixture of recombinant domains I and III using stopped-flow spectroscopy. In contrast to steady-state kinetic analysis, this procedure can reveal the presence of reaction intermediates. There are no other published descriptions of the pre-steady-state kinetics of reactions catalyzed by transhydrogenase. As hydride donor (binding to domain III), we use NADPH, and as hydride acceptor (binding to domain I), we use the NAD+ analogue, AcPdAD+.1 The difference in the absorbance spectra between the reduced forms of the two nucleotides enables us to measure the rate of oxidation of NADPH, and the rate of reduction of AcPdAD+, in real time.


MATERIALS AND METHODS

Recombinant forms of domain I and domain III of R. rubrum transhydrogenase were expressed in E. coli C600 from plasmids pCD1 (15) and pCD2 (16), respectively, and purified by column chromatography (15-17). The purity was confirmed by SDS-polyacrylamide gel electrophoresis (7), and the protein concentrations were determined using the microtannin assay (19). As normally prepared, the domain III protein is associated with tightly bound NADP+ (typically 0.1-0.4 mol·mol-1) and NADPH (about 0.5 mol·mol-1) (16). For stopped flow experiments the bound NADP+ was replaced by incubating domain III protein (75 µM) in 10 mM (NH4)2SO4, 20 mM Hepes buffer, pH 8.0, with 105 µM NADPH at 4 °C for 2 h (16).

Stopped-flow experiments were performed with an Applied Photophysics DX-17MV in its absorbance mode (2-mm optical path length). The instrument dead time, determined from the reaction of L-ascorbic acid with 2,6-dichlorophenolindophenol, as described (20), was 1.31 ms. The monochromator slit widths were set to 5 nm. The absorbance coefficient at 375 nm for AcPdAD+ reduction (corrected for the contribution from accompanying NADPH oxidation) was 6.1 mM-1·cm-1 (21) and that at 320 nm for NADPH oxidation (corrected for the contribution from accompanying AcPdAD+ reduction) was 3.01 mM-1·cm-1 (calculated from data given (22)). Rate constants and amplitudes were calculated from the raw data using the instrument software, making due correction for the apparatus dead time.

Samples of domains I and III were prepared for analysis by electrospray mass spectrometry by dialyzing samples (25 µM) against water. The examination of domain I was performed in collaboration with Dr. C. Robinson, University of Oxford, using a Micromass Platform II and Nanoflow electrospray ionization. Data were acquired using MassLynx software. The domain III analysis was carried out in collaboration with Dr. P. R. Ashton, University of Birmingham, using a VG-Prospec in electrospray ionization mode. In both cases the carrier matrix was 20% methanol. The precision of both instruments is better than ±0.01%. Molecular masses were estimated from the amino acid sequences of domains I and III using the Genetics Computer Group program (University of Wisconsin).


RESULTS AND DISCUSSION

The Molecular Weights of Domains I and III of R. rubrum Transhydrogenase Determined by Electrospray Mass Spectrometry

Table I shows the results of an analysis by electrospray mass spectrometry of the molecular masses of the purifed, recombinant domains I and III of R. rubrum transhydrogenase. In both cases only a single distinct charge envelope was evident in the raw data. The similarity between the measured molecular masses of domains I and III, and the values calculated from the amino acid sequences (23), eliminates the possibility of a bound prosthetic group or metal center.

Table I. The molecular masses of recombinant domain I and domain III proteins of R. rubrum transhydrogenase measured by electrospray mass spectrometry and calculated from the amino acid sequence


Mass spectrometry Amino acid sequence

Domain I 40,273 40,276
Domain III 21,469 21,466

Direct Transfer of Hydride from NADPH, Bound to Domain III, and AcPdAD+, Bound to Domain I, as Revealed by Stopped-flow Spectrophotometry

The experiment shown in Fig. 1 was set up to monitor hydride transfer from NADPH to AcPdAD+ in a mixture of the nucleotide-binding domains of R. rubrum transhydrogenase under pre-steady-state conditions. The first drive syringe of the stopped flow apparatus was filled with equimolar domain I and NADPH-loaded domain III proteins. The second drive syringe was filled with AcPdAD+. Upon mixing, the kinetics of AcPdAD+ reduction (Fig. 1A) were, within the resolution of the instrument, identical to the kinetics of NADPH oxidation (Fig. 1B), thus illustrating the direct hydride transfer between nucleotides. In both cases the reaction had the character of a "burst" before the onset of steady state. The steady-state rate is extremely slow, equivalent to approximately 0.025 A·s-1 at 375 nm in the conditions of the experiment and therefore negligible on the time scale displayed in Fig. 1; it is profoundly limited by the release of NADP+ from domain III (koff approx  0.03 s-1 (16)).
<UP>AcPdAD<SUP>+</SUP></UP>+E<UP>·NADPH → AcPdADH</UP>+E<UP>·NADP<SUP>+</SUP></UP> (Eq. 5)
A good fit to the burst was obtained by the sum of two exponentials. For AcPdAD+ reduction, the rate constants of the two phases were 490 and 8.6 s-1, and for NADPH oxidation, 511 s-1 and 8.3 s-1. These values are similar within the experimental error.


Fig. 1. Simultaneous oxidation of NADPH and reduction of AcPdAD+ by a mixture of the recombinant domains I and III of transhydrogenase from R. rubrum. Syringe one contained purified recombinant domain I (50 µM), NADPH-loaded domain III (50 µM), and carryover NADPH from the preincubation (final concentration: 70 µM, see text) in 10 mM (NH4)2SO4, 20 mM Hepes, pH 8.0 (NaOH). Syringe two contained 2 mM AcPdAD+, prepared by diluting a 20 mM stock solution of nucleotide in water with 10 mM (NH4)2SO4, 20 mM Hepes, pH 8.0 (NaOH). The reaction was initiated by mixing 50 µl from each syringe in the stopped-flow spectrophotometer. Each trace shown in the figure is an average of 10 recordings. A, AcPdAD+ reduction at 375 nm. B, NADPH oxidation at 320 nm, T = 8 °C.

[View Larger Version of this Image (13K GIF file)]


While it is clear that the product NADP+ remains on domain III during the burst (see above), we are not yet certain of the time scale of dissociation of the product AcPdADH. If the nucleotides do remain bound to the protein, then their absorbance coefficients might be somewhat distorted from those in free solution (for example, see Ref. 24). Nevertheless, using solution absorbance coefficients for the reduced nucleotides (see "Materials and Methods") the amplitudes of the fast and slow phases for AcPdAD+ reduction were 11.7 and 5.6 µM, respectively, and for NADPH oxidation, they were 9.1 and 4.1 µM, respectively. The minimal conclusion is that the proportion of fast and slow phases was similar for AcPdAD+ reduction and NADPH oxidation. The sum of the fast and slow phases corresponded to approximately 60% of the concentration of domain I and domain III in the reaction mixture (25 µM), indicating that the burst corresponds to a single turnover event. Although there will be some perturbation of the redox potential of the nucleotides in the protein binding sites (25), the reaction is expected to go substantially to completion (the Eo' values of NADP(H) and of AcPdAD(H) in solution are -320 and -248 mV, respectively (26)).

Fig. 2 shows the wavelength dependence of the fast and slow phases of the burst. Both components have a similar spectrum to that obtained by subtracting the molar absorbance spectra of NADPH and AcPdADH, though the possibility that the spectra of the reduced nucleotides on the enzyme are distorted by a few nanometers (see Ref. 24) cannot be excluded. No other intermediates can be identified in the spectrum.


Fig. 2. The spectra of the fast and slow phases of hydride transfer. Experiments were performed as in Fig. 1, except that T = 25 °C. Each experiment was run using the measuring wavelength indicated on the abscissa. From each of the resulting traces, the amplitudes of the fast and slow phases were calculated using the instrument software. black-diamond , amplitude of fast phase; square , amplitude of slow phase. For comparison, bullet  shows the simple difference spectrum between 5 µM NAD(P)H and 5 µM AcPdADH (calculated from spectra given in Ref. 22).

[View Larger Version of this Image (10K GIF file)]


Consequences for the Mechanism of Action of Transhydrogenase

It is clear from this work that hydride transfer between nucleotides bound to domains I and III of transhydrogenase proceeds directly and not by way of a reduced enzyme intermediate. This observation indicates that, during catalysis, the peripheral, nucleotide-binding domains must bring the C-4 atoms of the nicotinamide rings of NAD(H) and NADP(H) into juxtaposition. It rules out a number of models in which proton translocation was assumed to arise from chemical interactions between nucleotides and a putative hydride-accepting intermediate (reviewed (1)), and it complements our recent evidence that the hydride transfer step itself is not coupled to proton translocation (27). The indications that the coupling reactions involve changes in the nucleotide-binding energy, as suggested by a number of workers (3, 28, 29), are now very strong. We developed the view that proton translocation is coupled to events that are consequent on the binding and release of NADP+ and NADPH (28), and this was supported by the finding that NADP+ and NADPH release from domain III are promoted by interactions with the membrane-spanning domain II (16). The present observations, consistent with the interpretation that hydride transfer in I:III complexes is extremely rapid, and NADP+ release is very slow, lend further weight to the hypothesis.

Factors giving rise to the biphasic kinetics of the pre-steady-state burst remain to be investigated. Our preliminary interpretation is that the fast phase (k approx  500 s-1) corresponds to hydride transfer in preformed domain I·III complexes appropriately loaded with AcPdAD+ and NADPH, it therefore reflects the true intramolecular rate constant for the reaction, whereas the slow phase (k approx  8 s-1 at 8 °C) results from protein rearrangements and/or AcPdADH release. The steady-state cyclic reaction catalyzed by the R. rubrum domain I·III complex (the alternate reduction/oxidation of protein-bound NADP+/NADPH by NADH/AcPdAD+), with a kcat in the region of 100-200 s-1 at 30 °C (30), is expected to include contributions from both components.


FOOTNOTES

*   This work was supported by a project grant (to J. B. J.), and a studentship (to J. D. V.), from the Biotechnology and Biological Sciences Research Council and by a Wellcome Trust Prize studentship (to R. L. G.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence should be addressed. Tel.: 44-121-414-5423; Fax: 44-121-414-3982; E-mail: j.b.jackson{at}bham.ac.uk.
1   The abbreviations used are: AcPdAD+, acetylpyridine adenine dinucleotide.

ACKNOWLEDGEMENTS

We are very grateful to Carol Robinson and Peter Ashton for their help with the mass spectrometry analysis.


REFERENCES

  1. Jackson, J. B. (1991) J. Bioenerg. Biomembr. 23, 715-741 [CrossRef][Medline] [Order article via Infotrieve]
  2. Olausson, T., Fjellstrom, O., Meuller, J., and Rydstrom, J. (1995) Biochim. Biophys. Acta 1231, 1-19 [Medline] [Order article via Infotrieve]
  3. Hatefi, Y., and Yamaguchi, M. (1996) FASEB J. 10, 444-452 [Abstract]
  4. Fisher, R. R., and Guillory, R. J. (1971) J. Biol. Chem. 246, 4687-4693 [Abstract/Free Full Text]
  5. Jacobs, E., and Fisher, R. R. (1979) Biochemistry 18, 4315-4322 [Medline] [Order article via Infotrieve]
  6. Fisher, R. R., and Earle, S. R. (1982) in The Pyridine Nucleotide Coenzymes (Everse, J., Anderson, B. M., and You, K. S., eds), pp. 279-324, Academic Press, New York
  7. Lever, T. M., Palmer, T., Cunningham, I. J., Cotton, N. P. J., and Jackson, J. B. (1991) Eur. J. Biochem. 197, 247-255 [Medline] [Order article via Infotrieve]
  8. Stilwell, S. N., Bizouarn, T., and Jackson, J. B. (1997) Biochim. Biophys. Acta 1320, 83-94 [Medline] [Order article via Infotrieve]
  9. Hanson, R. L. (1979) J. Biol. Chem. 254, 888-893 [Free Full Text]
  10. Homyk, M., and Bragg, P. D. (1979) Biochim. Biophys. Acta 571, 201-217 [Medline] [Order article via Infotrieve]
  11. Enander, K., and Rydstrom, J. (1982) J. Biol. Chem. 257, 14760-14766 [Abstract/Free Full Text]
  12. Persson, B., and Rydstrom, J. (1987) Biochem. Biophys. Res. Commun. 142, 573-578 [Medline] [Order article via Infotrieve]
  13. Meuller, J., Hou, C., Bragg, P. D., and Rydstrom, J. (1997) Biochem. J. 234, 681-687
  14. Hojeberg, B., and Rydstrom, J. (1979) Methods Enzymol. 55, 275-283 [Medline] [Order article via Infotrieve]
  15. Diggle, C., Hutton, M., Jones, G. R., Thomas, C. M., and Jackson, J. B. (1995) Eur. J. Biochem. 228, 719-726 [Medline] [Order article via Infotrieve]
  16. Diggle, C., Bizouarn, T., Cotton, N. P. J., and Jackson, J. B. (1996) Eur. J. Biochem. 241, 162-170 [Medline] [Order article via Infotrieve]
  17. Cunningham, I. J., Williams, R., Palmer, T., Thomas, C. M., and Jackson, J. B. (1992) Biochim. Biophys. Acta 1100, 332-338 [CrossRef][Medline] [Order article via Infotrieve]
  18. Yamaguchi, M., and Hatefi, Y. (1997) Biochim. Biophys. Acta 1318, 225-234 [Medline] [Order article via Infotrieve]
  19. Mejbaum-Katzenellenbogen, S., and Drobryszycka, W. J. (1959) Clin. Chem. Acta 4, 515-522 [CrossRef]
  20. Tonomura, B., Nakatani, H., Ohnishi, M., Yamaguchi-Ito, J., and Hiromi, K. (1978) Anal. Biochem. 84, 370-383 [CrossRef][Medline] [Order article via Infotrieve]
  21. Palmer, T., and Jackson, J. B. (1992) Biochim. Biophys. Acta 1099, 157-162 [CrossRef][Medline] [Order article via Infotrieve]
  22. Siegel, J. M., Montgomery, G. A., and Bock, R. M. (1959) Arch. Biochem. Biophys. 82, 288-299 [CrossRef][Medline] [Order article via Infotrieve]
  23. Williams, R., Cotton, N. P. J., Thomas, C. M., and Jackson, J. B. (1994) Microbiology 140, 1595-1604 [Abstract]
  24. Rizzo, V., Pande, A., and Luisi, P. L. (1987) in Pyridine Nucleotide Coenzymes: Chemical, Biochemical and Medical Aspects Part A (Dolphin, D., Poulson, R., and Avramovic, O., eds), pp. 99-161, John Wiley & Sons, Inc., New York
  25. Bizouarn, T., Diggle, C., and Jackson, J. B. (1996) Eur. J. Biochem. 239, 737-741 [Medline] [Order article via Infotrieve]
  26. Woenckhaus, C., and Jeck, R. (1987) in Pyridine Nucleotide Coenzymes: Chemical, Biochemical and Medical Aspects Part A (Dolphin, D., Poulson, R., and Avramovic, O., eds), pp. 449-568, John Wiley & Sons, Inc., New York
  27. Bizouarn, T., Stilwell, S. N., Venning, J. D., Cotton, N. P. J., and Jackson, J. B. (1997) Biochim. Biophys. Acta, in press
  28. Hutton, M. N., Day, J. M., and Jackson, J. B. (1994) Eur. J. Biochem. 219, 1041-1051 [Medline] [Order article via Infotrieve]
  29. Hu, X., Zhang, J. W., Persson, A., and Rydstrom, J. (1995) Biochim. Biophys. Acta 1229, 64-72 [Medline] [Order article via Infotrieve]
  30. Bizouarn, T., Grimley, R. L., Diggle, C., Thomas, C. M., and Jackson, J. B. (1997) Biochim. Biophys. Acta 1320, 265-274 [Medline] [Order article via Infotrieve]

Volume 272, Number 44, Issue of October 31, 1997 pp. 27535-27538
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. H. C. Brondijk, G. I. van Boxel, O. C. Mather, P. G. Quirk, S. A. White, and J. B. Jackson
The Role of Invariant Amino Acid Residues at the Hydride Transfer Site of Proton-translocating Transhydrogenase
J. Biol. Chem., May 12, 2006; 281(19): 13345 - 13354.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Singh, J. D. Venning, P. G. Quirk, G. I. van Boxel, D. J. Rodrigues, S. A. White, and J. B. Jackson
Interactions between Transhydrogenase and Thio-nicotinamide Analogues of NAD(H) and NADP(H) Underline the Importance of Nucleotide Conformational Changes in Coupling to Proton Translocation
J. Biol. Chem., August 29, 2003; 278(35): 33208 - 33216.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Yamaguchi, C. D. Stout, and Y. Hatefi
The Proton Channel of the Energy-transducing Nicotinamide Nucleotide Transhydrogenase of Escherichia coli
J. Biol. Chem., September 6, 2002; 277(37): 33670 - 33675.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. Weston, J. D. Venning, and J. B. Jackson
The Membrane-peripheral Subunits of Transhydrogenase from Entamoeba histolytica Are Functional Only When Dimerized
J. Biol. Chem., July 12, 2002; 277(29): 26163 - 26170.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Fjellstrom, M. Axelsson, T. Bizouarn, X. Hu, C. Johansson, J. Meuller, and J. Rydstrom
Mapping of Residues in the NADP(H)-binding Site of Proton-translocating Nicotinamide Nucleotide Transhydrogenase from Escherichia coli. A STUDY OF STRUCTURE AND FUNCTION
J. Biol. Chem., March 5, 1999; 274(10): 6350 - 6359.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. D. Venning, S. J. Peake, P. G. Quirk, and J. B. Jackson
Stopped-flow Reaction Kinetics of Recombinant Components of Proton-translocating Transhydrogenase with Physiological Nucleotides
J. Biol. Chem., June 23, 2000; 275(26): 19490 - 19497.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. J. T. Pinheiro, J. D. Venning, and J. B. Jackson
Fast Hydride Transfer in Proton-translocating Transhydrogenase Revealed in a Rapid Mixing Continuous Flow Device
J. Biol. Chem., November 21, 2001; 276(48): 44757 - 44761.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Venning, J. D.
Right arrow Articles by Jackson, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Venning, J. D.
Right arrow Articles by Jackson, J. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.